SAN FRANCISCO–(BUSINESS WIRE)–Defined Research, Inc., a science-based wellness company announces the results of its clinical trial for Defined Sleep, a proprietary oral cannabidiol (CBD)-based formula. According to Harvard Medical School, the average U.S. worker loses 11.3 days, or $2,280, a national cost to the workforce of $63.2 billion due to insomnia. This CBD-terpene formulation resulted in an increase in both the percentage of time and the absolute time that participants spent in slow w
Source link
